NLRP3 and hepatocellular carcinoma: To verify whether a deletion of NLRP3 in HCC actually induces effective NK-mediated cancer immune surveillance in vivo, we intravenously injected WT or NLRP3 KO SK-Hep1-Luc cells to NRG mice, restrained in lymphocytes (B, T, and NK cells).